During the first week of May, the International Society of Magnetic Resonance in Medicine held their annual meeting in Stockholm, Sweden.

At the meeting, members from the AdMeTech Foundation’s International Prostate Cancer MRI Working Group delivered a consensus statement, which reviewed scientific data from major educational institutions in the U.S., Europe and Japan.  The group stated that, “the lack of accurate diagnostic tools for prostate cancer has led to a public health crisis.”  They suggested that an increase in diagnostic tools for prostate cancer such as magnetic resonance imaging (MRI) technology would not only improve the quality of life of millions of men, but reduce billions in healthcare expenditures.

During the annual meeting, members urged support towards the PRIME Act, which includes funding for research and development into the following:

  • new imaging technologies ($500 million)
  • more specific blood and urine tests for screening and prevention ($100 million)
  • prostate cancer education for men ($50 million)

The bill was introduced in March, 2010 and as of May 10, 2010 it was pending in the Senate Health, Education, Labor and Pensions Committee.

For more information please see: “Scientific Panel Cites Promise of MRI to Improve Prostate Cancer Diagnostics, Supports Federal Funding to End Public Health Crisis